Delgocitinib Cream for Hair Loss

This trial aims to test whether a cream called delgocitinib can safely and effectively treat frontal fibrosing alopecia, a type of hair loss affecting the front of the scalp. Participants will apply the cream to affected areas to determine its impact on symptoms like redness and scaling around hair follicles. The trial seeks adults with a confirmed diagnosis of this condition who experience moderate to severe symptoms. Participants should maintain consistent hair care routines and avoid certain treatments or products during the trial. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group of people.

Research has shown that delgocitinib cream is generally safe and well-tolerated for use over 24 weeks. Studies have found that patients often experienced hair regrowth and their condition stabilized while using the cream. Some side effects occurred, but these were usually mild, meaning they were not serious or harmful. Importantly, other studies found that the cream does not spread much beyond the application area, suggesting it is safe to use. Overall, the evidence indicates that delgocitinib cream is safe for treating hair loss.¹²³⁴⁵

Unlike traditional hair loss treatments that often involve oral medications or topical solutions like minoxidil and finasteride, Delgocitinib cream offers a novel approach by targeting the body's immune response. This cream is a JAK inhibitor, which means it works by blocking specific enzymes that play a role in inflammation and immune system activity. Researchers are excited about Delgocitinib because it has the potential to address an underlying cause of hair loss rather than just the symptoms, providing a more targeted treatment option. Additionally, as a topical cream, it may offer a convenient and potentially less systemic side effect profile compared to oral medications.

Research has shown that delgocitinib cream can help with hair loss. One study found that people using the cream experienced some hair regrowth and their condition stabilized after 24 weeks. Another study revealed that after 16 weeks, those using the cream had better results than those using a placebo. Delgocitinib also reduced inflammation, which is thought to contribute to certain types of hair loss, such as frontal fibrosing alopecia. Specifically, people treated with delgocitinib grew more hair compared to those who didn't use the cream. Overall, these findings suggest that delgocitinib cream could be a promising treatment for hair loss.¹³⁵⁶⁷